Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma

被引：0
|
作者：
I Sekine
H Nokihara
A Horiike
N Yamamoto
H Kunitoh
Y Ohe
T Tamura
T Kodama
N Saijo
机构：
[1] National Cancer Center Hospital,Divisions of Internal Medicine and Thoracic Oncology
[2] Tsukiji 5-1-1,undefined
[3] Chuo-ku,undefined
来源：
British Journal of Cancer | 2004年 / 90卷
关键词：
squamous cell carcinoma; paclitaxel; nedaplatin; lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The recommended phase II dose of paclitaxel 180 mg m−2 given as a 3-h infusion followed by nedaplatin 100 mg m−2 in a 1-h infusion every 3–4 weeks was determined in 52 chemo-naive patients with unresectable squamous cell carcinoma (SCC), with a promising response rate for lung SCC of 55%.
引用
收藏
页码：1125 / 1128
页数：3
相关论文
共 50 条
  • [1] Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma
    Sekine, I
    Nokihara, H
    Horiike, A
    Yamamoto, N
    Kunitoh, H
    Ohe, Y
    Tamura, T
    Kodama, T
    Saijo, N
    BRITISH JOURNAL OF CANCER, 2004, 90 (06) : 1125 - 1128
  • [2] Phase i study of cisplatin analogue nedaplatin, paclitaxel, and thoracic radiotherapy for unresectable stage III non-small cell lung cancer
    Sekine, Ikuo
    Sumi, Minako
    Ito, Yoshinori
    Kato, Terufumi
    Fujisaka, Yasuhito
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Kunitoh, Hideo
    Ohe, Yuichiro
    Tamura, Tomohide
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (03) : 175 - 180
  • [3] A phase II study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinoma
    He, Yi-Fu
    Ji, Chu-Shu
    Hu, Bing
    Fan, Ping-Sheng
    Hu, Chang-Lu
    Jiang, Feng-Shou
    Chen, Jian
    Zhu, Lei
    Yao, Yi-Wei
    Wang, Wei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (35) : 5910 - 5916
  • [4] A phase Ⅱ study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinoma
    Yi-Fu He
    Chu-Shu Ji
    Bing Hu
    Ping-Sheng Fan
    Chang-Lu Hu
    Feng-Shou Jiang
    Jian Chen
    Lei Zhu
    Yi-Wei Yao
    Wei Wang
    World Journal of Gastroenterology, 2013, (35) : 5910 - 5916
  • [5] Phase I Study of Nedaplatin Prior to S-1 in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma
    Sato, Dai
    Kogashiwa, Yasunao
    Tsukahara, Kiyoaki
    Yamauchi, Koichi
    Kohno, Naoyuki
    CHEMOTHERAPY, 2013, 59 (04) : 314 - 318
  • [6] Phase II study of nedaplatin and docetaxel in patients with advanced squamous cell carcinoma of the lung
    Naito, Y.
    Kubota, K.
    Ohmatsu, H.
    Goto, K.
    Niho, S.
    Yoh, K.
    Ohe, Y.
    ANNALS OF ONCOLOGY, 2011, 22 (11) : 2471 - 2475
  • [7] Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment
    Kajiura, Shinya
    Hosokawa, Ayumu
    Yoshita, Hiroki
    Ueda, Yuko
    Ueda, Akira
    Mihara, Hiroshi
    Ando, Takayuki
    Fujinami, Haruka
    Nishikawa, Jun
    Ogawa, Kohei
    Minemura, Masami
    Sugiyama, Toshiro
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (01): : 13 - 17
  • [8] Phase I study of chemoradiation with nedaplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix
    Kodama, J.
    Takemoto, M.
    Seki, N.
    Nakamura, K.
    Hongo, A.
    Moriya, S.
    Kanazawa, S.
    Hiramatsu, Y.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (06) : 1300 - 1304
  • [9] Multicenter Phase II Study of Nedaplatin and Irinotecan for Patients with Squamous Cell Carcinoma of the Lung: Thoracic Oncology Research Group 0910
    Yamada, Kouzo
    Saito, Haruhiro
    Kondo, Tetsuro
    Murakami, Shuji
    Masuda, Noriyuki
    Yamamoto, Michiko
    Igawa, Satoshi
    Katono, Ken
    Takiguchi, Yuichi
    Iwasawa, Shunichiro
    Kurimoto, Ryota
    Okamoto, Hiroaki
    Shimokawa, Tsuneo
    Hosomi, Yukio
    Takagi, Yusuke
    Kishi, Kazuma
    Ohba, Mari
    Oshita, Fumihiro
    Watanabe, Koshiro
    ANTICANCER RESEARCH, 2015, 35 (12) : 6705 - 6711
  • [10] In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers
    David S. Alberts
    Paul T. Fanta
    Kelli L. Running
    Laurence P. Adair Jr.
    Dava J. Garcia
    Rosa Liu-Stevens
    Sydney E. Salmon
    Cancer Chemotherapy and Pharmacology, 1997, 39 : 493 - 497
12345